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C14th International Congress on Infectious Diseases (ICID) Abs
EV71-IVIG should be developed for the treatment of fatal
EV71 infections.
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Polio controling Nigeria and other developing countries:
A systematic review/meta-analysi of literature on the use
of combined OPV & IPV measure as against OPV only
S.I. Ezikeanyi
Federal Ministry of Health Abuja, ABUJA, Nigeria
Background: Despite the overwhelming evidence-based
studies across the world on the efﬁcacy and effectiveness
of poliomyelitis eradication using the combined OPV & IPV
immunization schedule for children 0-59 months, Nigeria
still adheres to her policy on monovalent ‘Sabin’ live atten-
uated oral polio vaccine (mOPV1) that is only targeting
the type 1 strain among the three strains of the virus.
The question here is what informs Nigeria health policy
makers’ decision to continue with the current policy that
started since 2006 despite the persistent circulating Wild
Polio Virus (WPV) that has had its toll on children and drains
all efforts of achieving the MDGs 4 of reducing Child mor-
bidity and mortality come 2015. Empirical evidence from
a number of countries suggests that a policy on combined
Sabin live attenuated oral polio vaccine (OPV) and Salk killed
inactivated polio vaccine (IPV) in polio control program by
improving protection of children at individual levels and
at community level by conferring herd immunity can make
a major contribution to poliomyelitis control and possible
eradication of the persistent circulating wild polio strain and
its consequent disability and mortality.
Methods: A systematic literature review methodology
was used to identify relevant publications that reported the
use of OPV & IPV in the control of polio. Databases were
searched using different search terms. Of the 100 publica-
tions initially selected, 38 met the inclusion criteria and had
evidence level 1 and 2 ranking.
Results: The research revealed a remarkable reduction
in polio incidence in those countries. OPV & IPV was found
to reduce polio incidence or outbreak by 85%-90%, Acute
Flaccid Paralysis (AFP) by 85% and cost per child of 5$ for
full immunization coverage.
Conclusion: OPV & IPV combination has been shown to
be more effective than OPV alone and very potent in the
eradication of persistent strains of the virus. The author rec-
ommends the adoption of OPV & IPV by Nigeria as the main
dynamics of driving the polio immunization program towards
elimination or even total eradication of the wild circulat-
ing polio virus in Nigeria and other neighboring sub-Saharan
African countries.
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actors associated with outbreaks of measles in the
ighly immunized hilly areas of district Kangra, Himachal
radesh, India, 2007
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Background: Measles is the ﬁfth killer disease among chil-
ren under ﬁve years in the world. In Indian states, we are
n the heterogeneity of measles vaccination. In Himachal
radesh, despite high immunization coverage, the outbreaks
re occurring. Based upon two outbreaks, we conducted a
ase control study to identify factors associated with out-
reaks of measles and to recommend appropriate remedial
easures to prevent further outbreaks.
Methods: We reviewed the factors under three heads:
rogramme related, health care providers and beneﬁcia-
ies related. We used case-deﬁnition of measles adapted
y the WHO. We enrolled all 69 mothers of children with
easles. Controls were matched for age and sex. We used
pre-designed pre-tested data collection instrument. We
alculated the odds ratio and adjusted odds ratio with 95%
onﬁdence Interval (C.I.) among women of children exposed
nd unexposed to selected characteristics.
Results: Only beneﬁciary related issues were associ-
ted with outbreaks in case area which were indicated
y Focus Group Discussions and further conﬁrmed dur-
ng in-depth interviews in quantitative univariate analysis
ielding statistical signiﬁcance. Important socio-economic
ariables are Educational Status yielding to OR 27.63 (95%
.I. 9.46-85.16); Occupation with OR 0.35 (95% C.I. 0.16-
.75); Income with OR 5.49 (95% C.I. 2.36-13.00); mode of
ransport to the health care facility; OR 8.74 (95% C.I. 2.90-
8.23); First help contact when the child falls ill OR 2.12
95% C.I. 1.00-4.50). Knowledge about the child illness in the
amily, OR 5.03 (95% C.I. 0.95-35.17); Spread of illness from
ne person to other person OR 5.60 (95% C.I. 1.40-25.97)
nd Person for treatment, OR 2.85 (95 C.I. 1.27-6.46); Place
f visit after recovery from the measles, OR 3.92 (95% C.I.
.80-8.63). Multiple Logistic Regression yielded the signif-
cant variable as-educational status with AOR 438.72 (95%
.I. 17.0-11272.16).
Conclusion: Measles outbreaks were conﬁrmed in high
mmunization coverage areas. We recommend (i) 2nd dose
pportunity for measles (MMR) between 5 to 17 years; (ii)
mproving access to health care facility and (iii) IEC activi-
ies for social behavioral change rather than informing the
ommunity.
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